30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Pacific Biosciences of California Inc (PACB)

Track

In the last 90 days, Pacific Biosciences of California Inc. saw a net insider selling of $120,813.45. Two transactions were recorded, both sales, totaling $241,591.63. The company's stock has seen a 14.3% increase over the past 90 days. The last earnings report showed a 7.69% beat.
Stock chart
Ticker: PACB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gibson James R II
See Remarks
1 sale — total 120,813 USD
Sale 1 Apr 2026
Value US$3,517,439.21 | Price 169.06 | Shares 26,801
Proposed sale 1 Apr 2026
Value US$1,514,520.10 | Price 499.57 | Shares 76,934
Planned sale 3 Mar 2026
Value US$9,847.06 | Price 1.51 | Shares 6,504
Sale 3 Mar 2026
Value US$18,920.46 | Price 1.51 | Shares 12,497
Sale 3 Mar 2026
Value US$4,510.21 | Price 1.51 | Shares 2,979
Proposed sale 3 Mar 2026
Value US$9,849.01 | Price 1.51 | Shares 6,504
Proposed sale 3 Mar 2026
Value US$18,924.21 | Price 1.51 | Shares 12,497
Planned sale 18 Feb 2026
Value US$89,769.30 | Price 1.63 | Shares 55,107
Sale 18 Feb 2026
Value US$229,483.75 | Price 1.63 | Shares 140,874
Sale 18 Feb 2026
Value US$24,356.81 | Price 1.63 | Shares 14,952
Planned sale 17 Feb 2026
Value US$204,549.04 | Price 1.58 | Shares 129,790
Sale 17 Feb 2026
Value US$522,905.77 | Price 1.58 | Shares 331,793
Sale 17 Feb 2026
Value US$55,498.84 | Price 1.58 | Shares 35,215
Proposed sale 17 Feb 2026
Value US$478,692.66 | Price 1.58 | Shares 303,739
Proposed sale 17 Feb 2026
Value US$955,547.71 | Price 1.58 | Shares 606,312
Sale 18 Aug 2025
Value US$35,182.00 | Price 1.31 | Shares 26,836
Proposed sale 18 Aug 2025
Value US$35,173.95 | Price 1.31 | Shares 26,836
Sale 19 May 2025
Value US$5,200.20 | Price 1.00 | Shares 5,195
Sale 3 Mar 2025
Value US$4,183.01 | Price 1.41 | Shares 2,973
Sale 3 Mar 2025
Value US$17,583.28 | Price 1.41 | Shares 12,497
Planned sale 3 Mar 2025
Value US$9,125.80 | Price 1.41 | Shares 6,486
Proposed sale 3 Mar 2025
Value US$9,123.21 | Price 1.41 | Shares 6,486
Proposed sale 3 Mar 2025
Value US$17,578.28 | Price 1.41 | Shares 12,497
Sale 18 Feb 2025
Value US$45,727.42 | Price 1.88 | Shares 24,349
Sale 18 Feb 2025
Value US$189,251.69 | Price 1.88 | Shares 100,773
Sale 18 Feb 2025
Value US$488,109.10 | Price 1.88 | Shares 259,909
Proposed sale 18 Feb 2025
Value US$488,109.10 | Price 1.88 | Shares 259,909
Proposed sale 18 Feb 2025
Value US$189,251.69 | Price 1.88 | Shares 100,773
Proposed sale 10 Jan 2025
Value US$69,979.77 | Price 2.03 | Shares 34,405
Planned sale 10 Jan 2025
Value US$69,979.77 | Price 2.03 | Shares 34,405
Planned sale 30 Sep 2024
Value US$34,064.60 | Price 1.72 | Shares 19,782
Sale 16 Sep 2024
Value US$172,691.62 | Price 1.75 | Shares 98,907
Proposed sale 16 Sep 2024
Value US$172,741.08 | Price 1.75 | Shares 98,907
Planned sale 19 Aug 2024
Value US$42,601.92 | Price 1.59 | Shares 26,760
Proposed sale 19 Aug 2024
Value US$42,588.54 | Price 1.59 | Shares 26,760
Sale 16 Aug 2024
Value US$63,174.28 | Price 1.66 | Shares 38,011
Proposed sale 16 Aug 2024
Value US$63,189.49 | Price 1.66 | Shares 38,011
Sale 20 May 2024
Value US$10,708.25 | Price 2.03 | Shares 5,275
Buy 6 Mar 2024
Value US$176,160.00 | Price 4.40 | Shares 40,000
Sale 4 Mar 2024
Value US$69,056.17 | Price 4.87 | Shares 14,177
Planned sale 4 Mar 2024
Value US$14,457.13 | Price 4.87 | Shares 2,968
Planned sale 4 Mar 2024
Value US$25,694.52 | Price 4.87 | Shares 5,275
Planned sale 4 Mar 2024
Value US$44,745.01 | Price 4.87 | Shares 9,186
Proposed sale 4 Mar 2024
Value US$25,693.47 | Price 4.87 | Shares 5,275
Proposed sale 4 Mar 2024
Value US$44,743.17 | Price 4.87 | Shares 9,186
Proposed sale 4 Mar 2024
Value US$69,053.33 | Price 4.87 | Shares 14,177
Sale 20 Feb 2024
Value US$10,411.52 | Price 5.26 | Shares 1,979
Sale 20 Feb 2024
Value US$4,371.89 | Price 5.26 | Shares 831
Proposed sale 20 Feb 2024
Value US$4,371.56 | Price 5.26 | Shares 831
Proposed sale 20 Feb 2024
Value US$10,410.73 | Price 5.26 | Shares 1,979
Sale 16 Feb 2024
Value US$199,950.48 | Price 5.96 | Shares 33,560
Sale 16 Feb 2024
Value US$470,908.40 | Price 5.96 | Shares 79,038
Planned sale 16 Feb 2024
Value US$45,054.40 | Price 5.96 | Shares 7,562
Sale 16 Feb 2024
Value US$134,031.17 | Price 5.96 | Shares 22,496
Planned sale 16 Feb 2024
Value US$92,337.08 | Price 5.96 | Shares 15,498
Proposed sale 16 Feb 2024
Value US$199,953.84 | Price 5.96 | Shares 33,560
Proposed sale 16 Feb 2024
Value US$92,338.63 | Price 5.96 | Shares 15,498
Proposed sale 16 Feb 2024
Value US$470,916.31 | Price 5.96 | Shares 79,038
Proposed sale 16 Feb 2024
Value US$134,033.42 | Price 5.96 | Shares 22,496
Planned sale 9 Jan 2024
Value US$241,056.28 | Price 7.77 | Shares 31,012
Proposed sale 9 Jan 2024
Value US$241,065.58 | Price 7.77 | Shares 31,012
Planned sale 14 Dec 2023
Value US$200,000.00 | Price 10.00 | Shares 20,000
Proposed sale 14 Dec 2023
Value US$177,200.00 | Price 8.86 | Shares 20,000
Proposed sale 29 Sep 2023
Value US$162,477.09 | Price 8.44 | Shares 19,257
Planned sale 29 Sep 2023
Value US$162,471.31 | Price 8.44 | Shares 19,257
Sale 18 Sep 2023
Value US$980,254.97 | Price 10.12 | Shares 96,844
Proposed sale 18 Sep 2023
Value US$980,225.91 | Price 10.12 | Shares 96,844
Planned sale 11 Sep 2023
Value US$104,520.00 | Price 10.45 | Shares 10,000
Sale 17 Aug 2023
Value US$274,843.79 | Price 10.60 | Shares 25,936
Planned sale 17 Aug 2023
Value US$105,000.00 | Price 10.50 | Shares 10,000
Proposed sale 17 Aug 2023
Value US$274,833.42 | Price 10.60 | Shares 25,936
Proposed sale 17 Aug 2023
Value US$428,400.00 | Price 10.71 | Shares 40,000
Proposed sale 16 Aug 2023
Value US$287,114.17 | Price 11.00 | Shares 26,102
Sale 16 Aug 2023
Value US$287,122.00 | Price 11.00 | Shares 26,102
Proposed sale 16 Aug 2023
Value US$287,114.17 | Price 11.00 | Shares 26,102
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-03 2026-04-01 S Sale
Gibson James R II

See Remarks

Officer
26,801 -17.2%
169.06
US$3,517,439 		26,801 -17.2% 169.06 US$3,517,439
2026-04-01 2026-04-01 PrS Proposed sale
JAMES GIBSON

Officer

Officer
76,934
499.57
US$1,514,520 		76,934 499.57 US$1,514,520
2026-03-04 2026-03-03 PlS Planned sale
4.2
Van Oene Mark

See Remarks

Officer
52,809 +38.0%
19.79
US$3,057,966 		52,809 +38.0% 19.79 US$3,057,966
2026-03-04 2026-03-03 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
12,497 -0.3%
1.51
US$18,920 		12,497 -0.3% 1.51 US$18,920
2026-03-04 2026-03-03 S Sale
3.7
Farmer Michele

See Remarks

Officer
2,979 -1.0%
1.51
US$4,510 		2,979 -1.0% 1.51 US$4,510
2026-03-03 2026-03-03 PrS Proposed sale
4.2
MARK D. VAN OENE

Officer

Officer
6,504
1.51
US$9,849 		6,504 1.51 US$9,849
2026-03-03 2026-03-03 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
12,497
1.51
US$18,924 		12,497 1.51 US$18,924
2026-02-19 2026-02-18 PlS Planned sale
4.2
Van Oene Mark

See Remarks

Officer
55,107 -3.1%
1.63
US$89,769 		55,107 -3.1% 1.63 US$89,769
2026-02-19 2026-02-18 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
140,874 -5.0%
1.63
US$229,484 		140,874 -5.0% 1.63 US$229,484
2026-02-19 2026-02-18 S Sale
3.7
Farmer Michele

See Remarks

Officer
14,952 -6.4%
1.63
US$24,357 		14,952 -6.4% 1.63 US$24,357
2026-02-19 2026-02-17 PlS Planned sale
4.2
Van Oene Mark

See Remarks

Officer
129,790 -6.7%
1.58
US$204,549 		129,790 -6.7% 1.58 US$204,549
2026-02-19 2026-02-17 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
331,793 -10.5%
1.58
US$522,906 		331,793 -10.5% 1.58 US$522,906
2026-02-19 2026-02-17 S Sale
3.7
Farmer Michele

See Remarks

Officer
35,215 -13.1%
1.58
US$55,499 		35,215 -13.1% 1.58 US$55,499
2026-02-17 2026-02-17 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
303,739
1.58
US$478,693 		303,739 1.58 US$478,693
2026-02-17 2026-02-17 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
606,312
1.58
US$955,548 		606,312 1.58 US$955,548
2025-08-20 2025-08-18 S Sale
4.2
Van Oene Mark

See Remarks

Officer
26,836 -1.4%
1.31
US$35,182 		26,836 -1.4% 1.31 US$35,182
2025-08-18 2025-08-18 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
26,836
1.31
US$35,174 		26,836 1.31 US$35,174
2025-05-21 2025-05-19 S Sale
3.7
Farmer Michele

See Remarks

Officer
5,195 -1.9%
1.00
US$5,200 		5,195 -1.9% 1.00 US$5,200
2025-03-05 2025-03-03 S Sale
3.7
Farmer Michele

See Remarks

Officer
2,973 -1.6%
1.41
US$4,183 		2,973 -1.6% 1.41 US$4,183
2025-03-05 2025-03-03 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
12,497 -0.6%
1.41
US$17,583 		12,497 -0.6% 1.41 US$17,583
2025-03-05 2025-03-03 PlS Planned sale
4.2
Van Oene Mark

See Remarks

Officer
6,486 -0.4%
1.41
US$9,126 		6,486 -0.4% 1.41 US$9,126
2025-03-03 2025-03-03 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
6,486
1.41
US$9,123 		6,486 1.41 US$9,123
2025-03-03 2025-03-03 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
12,497
1.41
US$17,578 		12,497 1.41 US$17,578
2025-02-19 2025-02-18 S Sale
3.7
Farmer Michele

See Remarks

Officer
24,349 -11.5%
1.88
US$45,727 		24,349 -11.5% 1.88 US$45,727
2025-02-19 2025-02-18 S Sale
4.2
Van Oene Mark

See Remarks

Officer
100,773 -6.3%
1.88
US$189,252 		100,773 -6.3% 1.88 US$189,252
2025-02-19 2025-02-18 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
259,909 -10.4%
1.88
US$488,109 		259,909 -10.4% 1.88 US$488,109
2025-02-18 2025-02-18 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
259,909
1.88
US$488,109 		259,909 1.88 US$488,109
2025-02-18 2025-02-18 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
100,773
1.88
US$189,252 		100,773 1.88 US$189,252
2025-01-10 2025-01-10 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
34,405
2.03
US$69,980 		34,405 2.03 US$69,980
2025-01-10 2025-01-10 PlS Planned sale
4.2
Van Oene Mark

See Remarks

Officer
34,405 -2.1%
2.03
US$69,980 		34,405 -2.1% 2.03 US$69,980
2024-10-02 2024-09-30 PlS Planned sale
3.7
Kim Susan G.

See Remarks

Officer
19,782 -2.8%
1.72
US$34,065 		19,782 -2.8% 1.72 US$34,065
2024-09-17 2024-09-16 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
98,907 -3.8%
1.75
US$172,692 		98,907 -3.8% 1.75 US$172,692
2024-09-16 2024-09-16 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
98,907
1.75
US$172,741 		98,907 1.75 US$172,741
2024-08-20 2024-08-19 PlS Planned sale
3.1
Eidel Jeff

See Remarks

Officer
26,760 -3.0%
1.59
US$42,602 		26,760 -3.0% 1.59 US$42,602
2024-08-19 2024-08-19 PrS Proposed sale
3.1
JEFFREY EIDEL

Officer

Officer
26,760
1.59
US$42,589 		26,760 1.59 US$42,589
2024-08-20 2024-08-16 S Sale
4.2
Van Oene Mark

See Remarks

Officer
38,011 -2.3%
1.66
US$63,174 		38,011 -2.3% 1.66 US$63,174
2024-08-16 2024-08-16 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
38,011
1.66
US$63,189 		38,011 1.66 US$63,189
2024-05-22 2024-05-20 S Sale
3.7
Farmer Michele

See Remarks

Officer
5,275 -2.4%
2.03
US$10,708 		5,275 -2.4% 2.03 US$10,708
2024-03-06 2024-03-06 B Purchase
2.0
Meline David W
Non-Executive Director
40,000 +inf%
4.40
US$176,160 		40,000 +inf% 4.40 US$176,160
2024-03-06 2024-03-04 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
14,177 -0.5%
4.87
US$69,056 		14,177 -0.5% 4.87 US$69,056
2024-03-06 2024-03-04 PlS Planned sale
3.7
Farmer Michele

See Remarks

Officer
2,968 -1.3%
4.87
US$14,457 		2,968 -1.3% 4.87 US$14,457
2024-03-06 2024-03-04 PlS Planned sale
3.7
Kim Susan G.

See Remarks

Officer
5,275 -0.7%
4.87
US$25,695 		5,275 -0.7% 4.87 US$25,695
2024-03-06 2024-03-04 PlS Planned sale
4.2
Van Oene Mark

See Remarks

Officer
9,186 -0.5%
4.87
US$44,745 		9,186 -0.5% 4.87 US$44,745
2024-03-04 2024-03-04 PrS Proposed sale
3.7
SUSAN KIM

Officer

Officer
5,275
4.87
US$25,693 		5,275 4.87 US$25,693
2024-03-04 2024-03-04 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
9,186
4.87
US$44,743 		9,186 4.87 US$44,743
2024-03-04 2024-03-04 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
14,177
4.87
US$69,053 		14,177 4.87 US$69,053
2024-02-21 2024-02-20 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
1,979 -0.2%
5.26
US$10,412 		1,979 -0.2% 5.26 US$10,412
2024-02-21 2024-02-20 S Sale
3.7
Kim Susan G.

See Remarks

Officer
831 -0.3%
5.26
US$4,372 		831 -0.3% 5.26 US$4,372
2024-02-20 2024-02-20 PrS Proposed sale
3.7
SUSAN KIM

Officer

Officer
831
5.26
US$4,372 		831 5.26 US$4,372
2024-02-20 2024-02-20 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
1,979
5.26
US$10,411 		1,979 5.26 US$10,411
2024-02-21 2024-02-16 S Sale
4.2
Van Oene Mark

See Remarks

Officer
33,560 -3.7%
5.96
US$199,950 		33,560 -3.7% 5.96 US$199,950
2024-02-21 2024-02-16 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
79,038 -7.3%
5.96
US$470,908 		79,038 -7.3% 5.96 US$470,908
2024-02-21 2024-02-16 PlS Planned sale
3.7
Farmer Michele

See Remarks

Officer
7,562 -7.0%
5.96
US$45,054 		7,562 -7.0% 5.96 US$45,054
2024-02-21 2024-02-16 S Sale
3.7
Kim Susan G.

See Remarks

Officer
22,496 -7.3%
5.96
US$134,031 		22,496 -7.3% 5.96 US$134,031
2024-02-21 2024-02-16 PlS Planned sale
3.1
Eidel Jeff

See Remarks

Officer
15,498 -3.5%
5.96
US$92,337 		15,498 -3.5% 5.96 US$92,337
2024-02-16 2024-02-16 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
33,560
5.96
US$199,954 		33,560 5.96 US$199,954
2024-02-16 2024-02-16 PrS Proposed sale
3.1
JEFFREY EIDEL

Officer

Officer
15,498
5.96
US$92,339 		15,498 5.96 US$92,339
2024-02-16 2024-02-16 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
79,038
5.96
US$470,916 		79,038 5.96 US$470,916
2024-02-16 2024-02-16 PrS Proposed sale
3.7
SUSAN KIM

Officer

Officer
22,496
5.96
US$134,033 		22,496 5.96 US$134,033
2024-01-10 2024-01-09 PlS Planned sale
4.2
Van Oene Mark

See Remarks

Officer
31,012 -3.3%
7.77
US$241,056 		31,012 -3.3% 7.77 US$241,056
2024-01-09 2024-01-09 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
31,012
7.77
US$241,066 		31,012 7.77 US$241,066
2023-12-15 2023-12-14 PlS Planned sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
20,000 -1.8%
10.00
US$200,000 		20,000 -1.8% 10.00 US$200,000
2023-12-14 2023-12-14 PrS Proposed sale
4.1
CHRISTIAN HENRY

Director; Officer

Executive Director
20,000
8.86
US$177,200 		20,000 8.86 US$177,200
2023-09-29 2023-09-29 PrS Proposed sale
3.7
SUSAN KIM

Officer

Officer
19,257
8.44
US$162,477 		19,257 8.44 US$162,477
2023-09-29 2023-09-29 PlS Planned sale
3.7
Kim Susan G.

See Remarks

Officer
19,257 -5.9%
8.44
US$162,471 		19,257 -5.9% 8.44 US$162,471
2023-09-19 2023-09-18 S Sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
96,844 -8.1%
10.12
US$980,255 		96,844 -8.1% 10.12 US$980,255
2023-09-18 2023-09-18 PrS Proposed sale
4.1
CHRISTIAN HENRY

Officer

Officer
96,844
10.12
US$980,226 		96,844 10.12 US$980,226
2023-09-12 2023-09-11 PlS Planned sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
10,000 -0.8%
10.45
US$104,520 		10,000 -0.8% 10.45 US$104,520
2023-08-18 2023-08-17 S Sale
3.1
Eidel Jeff

See Remarks

Officer
25,936 -5.5%
10.60
US$274,844 		25,936 -5.5% 10.60 US$274,844
2023-08-18 2023-08-17 PlS Planned sale
4.1
HENRY CHRISTIAN O

See Remarks

Officer
10,000 -0.8%
10.50
US$105,000 		10,000 -0.8% 10.50 US$105,000
2023-08-17 2023-08-17 PrS Proposed sale
3.1
JEFFREY EIDEL

Officer

Officer
25,936
10.60
US$274,833 		25,936 10.60 US$274,833
2023-08-17 2023-08-17 PrS Proposed sale
4.1
CHRISTIAN HENRY

Director

Non-Executive Director
40,000
10.71
US$428,400 		40,000 10.71 US$428,400
2023-08-18 2023-08-16 PrS Proposed sale
4.2
Van Oene Mark

Officer

Officer
26,102
11.00
US$287,114 		26,102 11.00 US$287,114
2023-08-18 2023-08-16 S Sale
4.2
Van Oene Mark

See Remarks

Officer
26,102 -2.7%
11.00
US$287,122 		26,102 -2.7% 11.00 US$287,122
2023-08-16 2023-08-16 PrS Proposed sale
4.2
MARK VAN OENE

Officer

Officer
26,102
11.00
US$287,114 		26,102 11.00 US$287,114
Explore more

More insider trading research around Pacific Biosciences of California Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America